The pancreas is an important target for SARS-CoV-2 because angiotensin-converting enzyme 2 (ACE2) is expressed in both exocrine glands and pancreatic islets (12), and inflammation of pancreatic beta cells in COVID-19 patients also contributes to new-onset DM (13). This evidence concerns the gene ACE2 and COVID-19.